About us

  • Dr Nicholas Furtak-Wells, Dr Benjamin Dawson, and Dr Robert Mathieson have pioneered a revolution in quantum sensing; achieving a groundbreaking advancement in the field of glucose monitoring. NIQS Tech – a deep technology spin-out from Leeds University – was incorporated in 2022 to commercialise their cutting-edge research, which uniquely solves a key challenge in non-invasive glucose sensing that has plagued the industry for 50 years.

    To date, we have been awarded highly competitive Innovate UK grants and raised private equity investment which has enabled us to validate the technical and commercial feasibility of our technology, advancing it to TRL6, by completing ex-vivo studies, early human studies and developing a wearable-sized prototype device. The uniqueness and innovative nature of our approach, coupled with our dedication to advancing our technology has earned us widespread recognition.

    Our team has received numerous awards and accolades, notably the prestigious Royal Society of Chemistry (RSC) Emerging Technology award for Health in 2023.

  • NIQS’s mission is to revolutionise diabetes management without the need for needles or blood samples. Our focus is to develop a truly non-invasive, continuous, and accurate glucose sensing technology, aimed at improving diabetes management practices, and alleviating the burden of diabetes faced by both individuals and healthcare providers. Ultimately, we aim to empower people living with diabetes to live happier and healthier lives by removing the need for invasive and painful glucose management technologies, reducing their risk of diabetes-related complications and ultimately improving their quality of life.

  • Our vision is to become a global leader in diabetes management, while leveraging our core technology to address current and emerging needs in healthcare and beyond.  Our values underscore our commitment to improving global wellbeing, while upholding social and environmental responsibility. We strive to foster a positive, inclusive and engaging culture rooted in these core principles.

    By leveraging our groundbreaking core technology, we aim to make measuring your glucose levels as easy as telling the time.

Professor Ramzi Ajjan - Professor and Honorary Consultant in Diabetes and Endocrinology

Convenient and easy to use glucose monitors will be massively beneficial, as it will mean people are more likely to measure glucose more frequently.

More rigorous monitoring leads to better diabetes management.

This will lead to a lower chance of complications or prolonged periods of low/high glucose levels, and will lead to less expenditure by the NHS